Acquisition Announced

Tarsus Pharmaceuticals acquisition of iRenix Medical

US$75m consideration

Announced 8 Jul 2026

Advisers

iRenix Medical

Target

Financial adviser
Legal adviser

Tarsus Pharmaceuticals

Acquirer

Legal adviser
Target
iRenix Medical
Acquirer
Tarsus Pharmaceuticals
Target based in
United States
Buyer based in
United States
Sector
Ophthalmology
Tags
Ophthalmology, Drug Development, Pharma

In the league tables

Similar deals

All ophthalmology deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.